Successful Treatment of an Elderly Langerhans Cell Sarcoma Patient by EPOCH (etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin) Chemotherapy
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Pileri S, Grogan T, Harris N, Banks P, Campo E, Chan J
. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002; 41(1):1-29.
DOI: 10.1046/j.1365-2559.2002.01418.x.
View
2.
Kawase T, Hamazaki M, Ogura M, Kawase Y, Murayama T, Mori Y
. CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol. 2005; 81(4):323-9.
DOI: 10.1532/IJH97.04142.
View
3.
Bohn O, Ruiz-Arguelles G, Navarro L, Saldivar J, Sanchez-Sosa S
. Cutaneous Langerhans cell sarcoma: a case report and review of the literature. Int J Hematol. 2007; 85(2):116-20.
DOI: 10.1532/IJH97.NA0604.
View
4.
Feng H, Shuda M, Chang Y, Moore P
. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008; 319(5866):1096-100.
PMC: 2740911.
DOI: 10.1126/science.1152586.
View
5.
Deng A, Lee W, Pfau R, Harrington A, DiGiovani J, Prickett K
. Primary cutaneous Langerhans cell sarcoma without Birbeck granules: indeterminate cell sarcoma?. J Cutan Pathol. 2008; 35(9):849-54.
DOI: 10.1111/j.1600-0560.2007.00907.x.
View